We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Files Patent Infringement Suit Against Accord Healthcare Over Generic Januvia
Merck Files Patent Infringement Suit Against Accord Healthcare Over Generic Januvia
In a move to fend off a generic competitor, Merck hit Accord Healthcare with a patent infringement suit in a Delaware federal court over Accord’s generic version of its blockbuster diabetes drug Januvia (sitagliptin phosphate).